Neurogastrx

Neurogastrx is a developer of gastrointestinal disease therapeutics, with its product NG101 being a potent and selective peripheral nerve-targeted dopamine D2/D3 receptor antagonist. It is primarily used for symptoms such as gastroparesis and aims to improve the treatment of refractory gastrointestinal conditions by targeting the enteric nervous system.